SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549



                                    FORM 10-Q



[X]       QUARTERLY  REPORT  PURSUANT  TO SECTION 13 OR 15(d) OF THE  SECURITIES
          EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2003,

                                       OR

[ ]       TRANSITION  REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE  SECURITIES
          EXCHANGE ACT OF 1934 FOR THE TRANSITION  PERIOD FROM  ____________  TO
          ____________.




COMMISSION FILE NUMBER 1-14120



                        BLONDER TONGUE LABORATORIES, INC.
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


         DELAWARE                                          52-1611421
  ----------------------------                          ----------------
  (State or other jurisdiction                          (I.R.S. Employer
of incorporation or organization)                      Identification No.)


ONE JAKE BROWN ROAD, OLD BRIDGE, NEW JERSEY                     08857
- -------------------------------------------                   ----------
 (Address of principal executive offices)                     (Zip Code)


Registrant's telephone number, including area code:  (732) 679-4000


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

Yes   X    No
    -----     -----

Indicate  by check mark  whether  the  registrant  is an  accelerated  filer (as
defined in Rule 12b-2 of the Exchange Act).

Yes       No   X
    ----     ------

Number of shares of common  stock,  par value $.001,  outstanding  as of May 14,
2003: 7,522,027


                      The Exhibit Index appears on page 16.


                         PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                           CONSOLIDATED BALANCE SHEETS
                                 (IN THOUSANDS)




                                                                             March 31,    December
                                                                               2003      31, 2002
                                                                             --------    --------
              ASSETS (NOTE 4)                                              (unaudited)
                                                                                   
Current assets:
     Cash ................................................................   $     32    $    258
     Accounts receivable, net of allowance for doubtful
     accounts of $797 and $715 respectively ..............................      7,040       6,713
     Inventories, net (Note 3) ...........................................     23,634      24,760
     Notes receivable (Note 6) ...........................................        459         459
     Income tax receivable ...............................................        361         170
     Other current assets ................................................        520         556
     Deferred income taxes ...............................................      1,892       1,858
                                                                             --------    --------
         Total current assets ............................................     33,938      34,774
Notes receivable (Note 6) ................................................        857       1,019
Property, plant and equipment, net of accumulated
    depreciation and amortization ........................................      6,869       6,831
Patents, net .............................................................      2,998       3,120
Rights-of-Entry, net (Note 5) ............................................      1,477       1,396
Other assets, net ........................................................        948         951
Investment in Blonder Tongue Telephone LLC (Note 7) ......................        200          --
Deferred income taxes ....................................................      3,867       3,911
                                                                             --------    --------
                                                                             $ 51,154    $ 52,002
                                                                             ========    ========
              LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
     Current portion of long-term debt (Note 4) ..........................   $  2,634    $  2,632
     Accounts payable ....................................................      1,352         888
     Accrued compensation ................................................        597         514
     Accrued benefit liability ...........................................        196         196
     Other accrued expenses ..............................................        164         227
                                                                             --------    --------
         Total current liabilities .......................................      4,943       4,457
                                                                             --------    --------
Long-term debt (Note 4) ..................................................     13,771      14,278
Stockholders' equity:
     Preferred stock, $.001 par value; authorized 5,000 shares;
     no shares outstanding ...............................................         --          --
     Common stock, $.001 par value; authorized 25,000 shares, 8,445 shares
     Issued ..............................................................          8           8
     Paid-in capital .....................................................     24,145      24,145
     Retained earnings ...................................................     15,233      15,991
     Accumulated other comprehensive loss ................................       (508)       (508)
     Treasury stock, at cost, 922 shares and 879 shares, respectively ....     (6,438)     (6,369)
                                                                             --------    --------
         Total stockholders' equity ......................................     32,440      33,267
                                                                             --------    --------
                                                                             $ 51,154    $ 52,002
                                                                             ========    ========


See accompanying notes to consolidated financial statements.

                                       2


               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF OPERATIONS
                    (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
                                   (UNAUDITED)



                                                                    Three Months Ended
                                                                         March 31,
                                                                   --------------------
                                                                     2003       2002
                                                                   --------    --------
                                                                         
Net sales ......................................................   $  8,602    $ 10,890
Cost of goods sold .............................................      6,443       7,574
                                                                   --------    --------
    Gross profit ...............................................      2,159       3,316
                                                                   --------    --------
Operating expenses:
    Selling ....................................................        998       1,118
    General and administrative .................................      1,564       1,197
    Research and development ...................................        548         497
                                                                   --------    --------
                                                                      3,110       2,812
                                                                   --------    --------
Earnings (loss) from operations ................................       (951)        504
                                                                   --------    --------

    Interest expense ...........................................       (273)       (211)
                                                                   --------    --------

Earnings (loss) before income taxes ............................     (1,224)        293
Provision (benefit) for income taxes ...........................       (466)        110
                                                                   --------    --------
Earnings (loss) before cumulative effect .......................       (758)        183
Cumulative effect of change in
  accounting principle, net of tax .............................         --      (6,886)
                                                                   --------    --------
Net loss .......................................................   $   (758)   $ (6,703)
                                                                   ========    ========
Basic earnings (loss) per share before cumulative effect .......   $  (0.10)   $   0.02
Cumulative effect of change in accounting
  principle, net of tax ........................................         --       (0.90)
                                                                   --------    --------
Basic loss per share ...........................................   $  (0.10)   $  (0.88)
                                                                   ========    ========
Basic weighted average shares outstanding ......................      7,539       7,613
                                                                   ========    ========
Diluted earnings (loss) per share before cumulative effect .....   $  (0.10)   $   0.02
Cumulative effect of change in
  accounting principle, net of tax .............................         --       (0.90)
                                                                   --------    --------
Diluted loss per share .........................................   $  (0.10)   $  (0.88)
                                                                   ========    ========
Diluted weighted average shares outstanding ....................      7,539       7,613
                                                                   ========    ========



See accompanying notes to consolidated financial statements.

                                       3


               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (IN THOUSANDS)
                                   (UNAUDITED)



                                                             Three Months Ended
                                                                   March 31,
                                                             --------------------
                                                               2003       2002
                                                             --------    --------
                                                                   
Cash Flows From Operating Activities:
     Net loss ............................................   $   (758)   $ (6,703)
     Adjustments to reconcile net earnings to cash
     provided by (used in) operating activities:
       Cumulative effect of change in
         accounting principle ............................         --       6,886
       Depreciation ......................................        285         324
       Amortization ......................................        191         107
       Provision for doubtful accounts ...................         90          90
       Deferred income taxes .............................         10        (115)
       Changes in operating assets and liabilities:
         Accounts receivable .............................       (417)      2,225
         Inventories .....................................      1,126           2
         Other current assets ............................         36         216
         Other assets ....................................          3        (178)
         Income taxes ....................................       (191)        225
         Accounts payable and accrued expenses ...........        484      (1,450)
                                                             --------    --------
         Net cash provided by operating activities .......        859       1,629
                                                             --------    --------
Cash Flows From Investing Activities:
     Capital expenditures ................................       (323)        (29)
     Receipts from note receivable .......................        162          --
     Investment in Blonder Tongue Telephone, LLC .........       (200)         --
     Acquisition of rights-of-entry ......................       (150)         --
                                                             --------    --------
     Net cash used in investing activities ...............       (511)        (29)
                                                             --------    --------
Cash Flows From Financing Activities:
     Borrowings of long-term debt ........................      2,430      14,954
     Repayments of long-term debt ........................     (2,935)    (17,103)
     Acquisition of treasury stock .......................        (69)         --
                                                             --------    --------
           Net cash used in financing activities .........       (574)     (2,149)
                                                             --------    --------
Net decrease in cash .....................................       (226)       (549)
Cash, beginning of period ................................        258         942
                                                             --------    --------
Cash, end of period ......................................   $     32    $    393
                                                             ========    ========
Supplemental Cash Flow Information:
     Cash paid for interest ..............................   $    187    $    243
     Cash paid for income taxes ..........................         --          --
                                                             ========    ========



See accompanying notes to consolidated financial statements.

                                       4


               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (IN THOUSANDS)
                                   (UNAUDITED)


NOTE 1 - COMPANY AND BASIS OF PRESENTATION

     Blonder  Tongue   Laboratories,   Inc.  (the   "COMPANY")  is  a  designer,
manufacturer  and supplier of  electronics  and systems  equipment for the cable
television  industry,  primarily  throughout the United States. The consolidated
financial statements include the accounts of Blonder Tongue  Laboratories,  Inc.
and subsidiaries.  Significant  intercompany accounts and transactions have been
eliminated in consolidation.

     The results for the first quarter of 2003 are not necessarily indicative of
the results to be expected  for the full fiscal year and have not been  audited.
In the opinion of management,  the accompanying unaudited consolidated financial
statements  contain  all  adjustments,   consisting  only  of  normal  recurring
accruals,  necessary for a fair  statement of the results of operations  for the
period presented and the consolidated  balance sheet at March 31, 2003.  Certain
information and footnote  disclosure  normally included in financial  statements
prepared in accordance with generally accepted  accounting  principles have been
condensed or omitted pursuant to the SEC rules and regulations.  These financial
statements should be read in conjunction with the financial statements and notes
thereto that were  included in the  Company's  latest annual report on Form 10-K
for the year ended December 31, 2002.

NOTE 2 - STOCK OPTIONS

     The Company  applies APB Opinion  No. 25,  Accounting  for Stock  Issued to
Employees, and related interpretations in accounting for its stock option plans.
Statement of Financial Accounting Standards No. 123 ("FAS 123"),  Accounting for
Stock-Based Compensation,  requires the Company to provide pro forma information
regarding net income and net income per common share as if compensation cost for
stock options  granted under the plans,  if applicable,  had been  determined in
accordance  with the fair value based method  prescribed in FAS 123. The Company
does not plan to adopt the fair value based method prescribed by FAS 123.

     The Company  estimates  the fair value of each stock  option grant by using
the  Black-Scholes  option-pricing  model with the  following  weighted  average
assumptions  used for grants:  expected lives of 9.5 years,  no dividend  yield,
volatility  at 73%,  risk free  interest rate of 3.2% for the three months ended
March 31, 2002. No options were granted  during the three months ended March 31,
2003.

     Under  accounting  provisions  of FAS 123, the Company's net loss to common
shareholders  and net loss per common share would have been  adjusted to the pro
forma amounts indicated below (in thousands, except per share data):


                                                           Three Months
                                                           Ended March 31
                                                         ------------------
                                                          2003       2002
                                                         -------    -------
Net loss as reported .................................   $  (758)   $(6,703)
Adjustment for fair value of stock options,
 net of tax ..........................................        78        148
                                                         -------    -------
     Pro forma .......................................   ($  836)   ($6,851)
                                                         =======    =======
Net loss per share basic and diluted:
     As reported .....................................   $ (0.10)   $ (0.88)
                                                         =======    =======
     Pro forma .......................................   $ (0.11)   $ (0.90)
                                                         =======    =======

                                       5


               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (IN THOUSANDS)
                                   (UNAUDITED)

NOTE 3 - INVENTORIES

     Inventories net of reserves are summarized as follows:


                                                     March 31,          Dec. 31,
                                                      2003                2002
                                                     -------             -------
Raw Materials ..........................             $10,784             $11,054
Work in process ........................               1,633               1,660
Finished Goods .........................              11,217              12,046
                                                     -------             -------
                                                     $23,634             $24,760
                                                     =======             =======

NOTE 4 - DEBT

     On March 20, 2002 the Company  executed a credit  agreement  with  Commerce
Bank, N.A. for a $19,500 credit  facility,  comprised of (i) a $7,000  revolving
line of credit under which funds may be borrowed at LIBOR, plus a margin ranging
from  1.75% to 2.50%,  in each case  depending  on the  calculation  of  certain
financial covenants,  with a floor of 5% through March 19, 2003 (5% at March 31,
2003),  (ii) a $9,000 term loan which bears  interest at a rate of 6.75% through
September 30, 2002,  and  thereafter at a fixed rate ranging from 6.50% to 7.25%
to reset quarterly  depending on the calculation of certain financial  covenants
(6.75% at March 31, 2003) and (iii) a $3,500  mortgage loan bearing  interest at
7.5%.  Borrowings  under the  revolving  line of credit  are  limited to certain
percentages of eligible  accounts  receivable  and inventory,  as defined in the
credit  agreement.  The credit facility is collateralized by a security interest
in all of the Company's  assets.  The agreement also contains  restrictions that
require the Company to maintain certain financial ratios as well as restrictions
on the payment of cash  dividends.  The maturity date of the line of credit with
Commerce Bank is April 1, 2004. The term loan requires  equal monthly  principal
payments of $187 and matures on April 1, 2006.  The mortgage loan requires equal
monthly  principal  payments of $19 and matures on April 1, 2017.  The  mortgage
loan is callable after five years at the lender's option.

     Upon  execution of the credit  agreement  with Commerce  Bank,  $14,954 was
advanced to the Company,  of which $14,827 was used to pay all unpaid  principal
and accrued  interest  under the  Company's  prior line of credit and term loans
with First Union National Bank.

     At March 31, 2003, there was $5,595,  $6,750 and $3,267  outstanding  under
the revolving line of credit, term loan and mortgage loan, respectively.

     At March 31,  2003,  the  Company  was unable to meet one of its  financial
covenants  under its credit  agreement with its bank,  compliance with which was
waived by such bank as of March 31, 2003.

NOTE 5 - RIGHTS OF ENTRY ACQUISITION (DOLLARS IN THOUSANDS)

     During June, 2002, the Company formed a venture with Priority Systems,  LLC
and  Paradigm  Capital  Investments,  LLC  for  the  purpose  of  acquiring  the
rights-of-entry for certain multiple dwelling unit cable television systems (the
"SYSTEMS")  owned by  affiliates  of Verizon  Communications,  Inc.  The venture
entity,  BDR Broadband,  LLC ("BDR BROADBAND"),  80% of the outstanding  capital
stock of  which  is  owned by the  Company,  acquired  the  Systems,  which  are
comprised of approximately  3,270 existing MDU cable television  subscribers and
approximately  7,340 passings.  BDR Broadband paid approximately  $1,880 for the
Systems, subject to adjustment,  which constitutes a purchase price of $.575 per
subscriber.  The final closing date for the  transaction  was on October 1, 2002
and BDR Broadband has been reflected in the consolidated  results of the Company
since that date. The Systems are expected to be cash flow positive  beginning in
the  first  year.  It  is  planned  that  the  Systems  will  be  upgraded  with
approximately  $1,300 of interdiction and other products of the Company over the
course of operation.

                                       6


               BLONDER TONGUE LABORATORIES, INC. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 (IN THOUSANDS)
                                   (UNAUDITED)

     The purchase price  (excluding  transaction  costs) was allocated $1,489 to
rights-of-entry and $391 to fixed assets. The rights-of-entry  will be amortized
over a five year period.

     In consideration  for its majority  interest in BDR Broadband,  the Company
advanced to BDR Broadband $250,  which was paid to the sellers as a down payment
against the final  purchase  price for the  Systems.  The Company also agreed to
guaranty  payment  of the  aggregate  purchase  price  for  the  Systems  by BDR
Broadband.

     The  approximately  $1,630  balance of the  purchase  price was paid by the
Company on behalf of BDR  Broadband on November  30, 2002  pursuant to the terms
and in  satisfaction  of certain  promissory  notes executed by BDR Broadband in
favor of the sellers.

NOTE 6 - NOTES RECEIVABLE

     During   September   2002,   the  Company  sold  inventory  at  a  cost  of
approximately  $1,447 to a private cable  operator for  approximately  $1,929 in
exchange for which the Company received notes receivable in the principal amount
of  approximately  $1,929.  The notes are payable by the  customer in 48 monthly
principal and interest (at 11.5%)  installments of approximately  $51 commencing
January  1,  2003.  The  customer's  payment  obligations  under  the  notes are
collateralized  by purchase money liens on the inventory sold and blanket second
liens on all other  assets of the  customer.  The Company has recorded the notes
receivable  at the  inventory  cost and will not  recognize any revenue or gross
profit  on the  transaction  until a  substantial  amount  of the  cost has been
recovered.

NOTE 7 - ACQUISITION

     In March,  2003, the Company entered into a series of agreements,  pursuant
to which the Company acquired a 20% minority interest in NetLinc Communications,
LLC ("NETLINC")  and a 35% minority  interest in Blonder Tongue  Telephone,  LLC
("BTT") (to which the Company has licensed  its name).  The  aggregate  purchase
price  consists of (i) up to $3,500  payable  over a minimum of two years,  plus
(ii) 500 shares of the Company's  common stock.  Of the $3,500 payable under the
agreements,  the  Company's  obligation  to pay  $2,500 is  contingent  upon BTT
achieving specified targeted monthly earnings objectives.  As of March 31, 2003,
$200 has been paid.

                                       7


ITEM 2. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

FORWARD-LOOKING STATEMENTS

     In addition to  historical  information,  this  Quarterly  Report  contains
forward-looking  statements  relating to such matters as  anticipated  financial
performance,  business  prospects,  technological  developments,  new  products,
research and development  activities and similar matters. The Private Securities
Litigation  Reform  Act of  1995  provides  a safe  harbor  for  forward-looking
statements.  In order to comply with the terms of the safe  harbor,  the Company
notes that a variety of factors  could cause the  Company's  actual  results and
experience  to  differ   materially  from  the  anticipated   results  or  other
expectations expressed in the Company's  forward-looking  statements.  The risks
and uncertainties  that may affect the operation,  performance,  development and
results of the Company's business include, but are not limited to, those matters
discussed  herein in the section  entitled Item 2 - Management's  Discussion and
Analysis of Financial Condition and Results of Operations.  The words "believe",
"expect",    "anticipate",    "project"   and   similar   expressions   identify
forward-looking statements. Readers are cautioned not to place undue reliance on
these forward-looking statements, which reflect management's analysis only as of
the date hereof.  The Company  undertakes no obligation to publicly revise these
forward-looking  statements to reflect events or circumstances  that arise after
the date hereof.  Readers should carefully review the risk factors  described in
other  documents  the Company  files from time to time with the  Securities  and
Exchange Commission,  including without limitation,  the Company's Annual Report
on Form 10-K for the year ended December 31, 2002 (See Item 1 - Business; Item 3
- - Legal  Proceedings;  and Item 7 -  Management's  Discussion  and  Analysis  of
Financial Condition and Results of Operations).

GENERAL

     During June, 2002, the Company formed a venture with Priority Systems,  LLC
and  Paradigm  Capital  Investments,  LLC  for  the  purpose  of  acquiring  the
rights-of-entry for certain multiple dwelling unit cable television systems (the
"SYSTEMS")  owned by  affiliates  of Verizon  Communications,  Inc.  The venture
entity, BDR Broadband, 80% of the outstanding capital stock of which is owned by
the Company,  acquired the Systems,  which are comprised of approximately  3,270
existing MDU cable television  subscribers and approximately 7,340 passings. BDR
Broadband paid approximately  $1,880,000 for the Systems, subject to adjustment,
which  constitutes a purchase  price of $575 per  subscriber.  The final closing
date for the  transaction was on October 1, 2002. The Systems are expected to be
cash flow  positive  beginning in the first year. It is planned that the Systems
will be  upgraded  with  approximately  $1,300,000  of  interdiction  and  other
products of the Company over the course of operation.

     In consideration  for its majority  interest in BDR Broadband,  the Company
advanced  to BDR  Broadband  $250,000,  which was paid to the  sellers as a down
payment  against the final  purchase  price for the  Systems.  The Company  also
agreed to guaranty  payment of the aggregate  purchase  price for the Systems by
BDR Broadband.  The approximately  $1,630,000  balance of the purchase price was
paid by the Company on behalf of BDR  Broadband on November 30, 2002 pursuant to
the terms and in satisfaction of certain  promissory  notes (the "SELLER NOTES")
executed by BDR Broadband in favor of the sellers.

     The Company believes that similar opportunities  currently exist to acquire
additional  rights-of-entry  for multiple dwelling unit cable television systems
at historically low prices.  The Company also believes that the model it devised
for acquiring and operating the Systems will be successful and can be replicated
for other transactions with the same or new venture partners.  Accordingly,  the
Company is currently  seeking and  assessing  various  opportunities  to acquire
additional  rights-of-entry  via venture  arrangements  with third  parties that
would  market and operate  the  systems.  As of the date  hereof,  however,  the
Company  does  not have  any  binding  commitments  or  agreements  for any such
acquisitions.  Moreover, even if attractive opportunities arise, the Company may
need financing to acquire the rights-of-entry for such cable systems. Given that
financing may not be available on acceptable terms or at all, the Company may be
unable to pursue these opportunities.

     In March,  2003, the Company entered into a series of agreements,  pursuant
to which the Company acquired

                                       8


a 20% minority  interest in NetLinc  Communications,  LLC  ("NETLINC") and a 35%
minority interest in Blonder Tongue Telephone, LLC ("BTT") (to which the Company
has licensed  its name).  The  aggregate  purchase  price  consists of (i) up to
$3,500,000  payable over a minimum of two years, plus (ii) 500,000 shares of the
Company's common stock. Of the $3,500,000 payable under the agreements,  Blonder
Tongue's obligation to pay $2,500,000 is contingent upon BTT achieving specified
targeted monthly earnings  objectives.  As of March 31, 2003,  $200,000 has been
paid.

     NetLinc is the owner of patents,  proprietary  technology  and know-how for
certain  telephony  products  that allow  Competitive  Local  Exchange  Carriers
("CLECs")  to  competitively  provide  voice  service  to  MDUs.  Pursuant  to a
distributorship  agreement  between  NetLinc  and  BTT,  BTT has  the  exclusive
worldwide  distribution  rights,  subject  to  certain  limited  exceptions,  to
NetLinc's products.  In turn,  pursuant to a distribution  agreement between BTT
and Blonder  Tongue,  Blonder  Tongue has obtained from BTT exclusive  worldwide
distribution  rights,  subject  to  certain  limited  exceptions,  to those same
products  for sale to private and  franchise  cable  operators as well as to all
buyers for use in MDU applications. As part of the overall series of agreements,
Blonder  Tongue has licensed the right to use the name "Blonder  Tongue" to BTT,
thereby  allowing the venture to  capitalize  upon the goodwill that the Company
has developed over its 50+ years in business.  It is contemplated  that BTT will
partner with CLECs to offer the telephony  solution,  receiving a portion of the
line  charges  due from the CLECs'  telephone  customers.  Blonder  Tongue  will
receive incremental  revenues and profits associated with sales of the telephony
products.  In addition,  through its 35% stake in BTT,  Blonder Tongue will also
receive a portion of the voice service revenues earned by BTT.

First three months of 2003 Compared with first three months of 2002

     Net Sales. Net sales decreased $2,288,000 or 21% to $8,602,000 in the first
three months of 2003 from  $10,890,000  in the first three  months of 2002.  The
decrease in sales is primarily  attributed to a decrease in capital  spending by
cable system operators and weak overall economic  conditions.  As a result,  the
Company  experienced  lower  interdiction  and digital product sales.  Net sales
included  approximately  $775,000 and  $1,336,000  of  interdiction  and digital
equipment  for  the  first  three  months  of  2003  compared  to  approximately
$1,014,000 and $2,139,000 for the first three months of 2002.

     Cost of Goods Sold.  Cost of goods sold  decreased  to  $6,443,000  for the
first three months of 2003 from  $7,574,000  for the first three months of 2002,
primarily  due to decreased  volume but  increased  as a percentage  of sales to
74.9% from 69.6%.  The increase as a percentage of sales was caused primarily by
a higher  portion of sales  during the period  being  comprised  of lower margin
product, including the Motorola QAM decoder.

     Selling  Expenses.  Selling  expenses  decreased  to $998,000 for the first
three  months of 2003 from  $1,118,000  in the  first  three  months of 2002 but
increased as a  percentage  of sales to 11.6% for the first three months of 2003
from  10.3% for the  first  three  months of 2002.  This  $120,000  decrease  is
primarily attributable to a decrease in wages and fringe benefits of $34,000 due
to a reduction  in  headcount,  along with a reduction in freight of $50,000 and
commissions of $24,000 due to reduced sales levels.

     General and Administrative  Expenses.  General and administrative  expenses
increased to $1,564,000  for the first three months of 2003 from  $1,197,000 for
the first three months of 2002 and  increased as a percentage  of sales to 18.2%
for the first  three  months of 2003 from  11.0% for the first  three  months of
2002. The $367,000 increase can be primarily  attributed to professional fees of
$109,000,  depreciation  and  amortization of $97,000 and operating  expenses of
$123,000, all of which related to BDR Broadband.

     Research  and  Development  Expenses.  Research  and  development  expenses
increased  to $548,000 in the first  three  months of 2003 from  $497,000 in the
first three  months of 2002.  This  $51,000  increase  was  primarily  due to an
increase in licensing  fees of $16,000 and an $18,000  increase in  departmental
supplies. Research and development expenses, as a percentage of sales, increased
to 6.4% in the first three months of 2003 from 4.6% in the first three months of
2002.

     Operating Income (Loss). Operating income (loss) was a loss of $951,000 for
the first three  months of 2003  compared  to income of  $504,000  for the first
three months of 2002.

                                       9


     Interest Expense. Interest expense increased to $273,000 in the first three
months of 2003 from $211,000 in the first three months of 2002.  The increase is
the result of higher average borrowing.

     Income Taxes. The provision  (benefit) for income taxes for the first three
months of 2003 was a benefit of $466,000 compared to a provision of $110,000 for
the first three months of 2002 as a result of a decrease in taxable income.

     Cumulative Effect of Change in Accounting Principle. During the first three
months of 2002, the Company implemented FAS 142, which resulted in the write off
of  $10,760,000  of the net book  value of  goodwill,  offset by the  future tax
benefit thereof in the amount of $3,874,000.  The net cumulative  effect of this
change in accounting  principles was a non-recurring  $6,886,000  charge against
earnings in the first three months of 2002.

LIQUIDITY AND CAPITAL RESOURCES

     As of March 31, 2003 and December 31, 2002, the Company's  working  capital
was $28,995,000 and $30,317,000,  respectively.  The decrease in working capital
is attributable  primarily to a reduction of inventory of $1,126,000  along with
an increase in accounts payable and accrued expenses of $484,000.

     The Company's net cash provided by operating activities for the three-month
period  ended March 31,  2003 was  $859,000,  compared  to net cash  provided by
operating  activities for the three-month period ended March 31, 2002, which was
$1,629,000. The decrease in net cash is primarily due to a decrease in inventory
offset by a decrease in accounts payable and accrued expenses.

     Cash used in investing  activities was $511,000,  which was attributable to
capital expenditures for new equipment and upgrades to the BDR Broadband Systems
of $323,000 and a $200,000 investment in BTT.

     Cash used in financing  activities  was $574,000 for the first three months
of 2003 primarily  comprised of $2,430,000 of borrowings offset by $2,935,000 of
repayments of long term debt.

     On March 20, 2002 the Company  executed a credit  agreement  with  Commerce
Bank,  N.A. for a  $19,500,000  credit  facility,  comprised of (i) a $7,000,000
revolving  line of credit  under which  funds may be  borrowed at LIBOR,  plus a
margin ranging from 1.75% to 2.50%, in each case depending on the calculation of
certain  financial  covenants,  with a floor of 5% through March 19, 2003 (5% at
March 31, 2003),  (ii) a $9,000,000  term loan which bears interest at a rate of
6.75% through  September 30, 2002,  and  thereafter at a fixed rate ranging from
6.50% to 7.25%  to reset  quarterly  depending  on the  calculation  of  certain
financial  covenants  (6.75% at March 31, 2003) and (iii) a $3,500,000  mortgage
loan bearing interest at 7.5%. Borrowings under the revolving line of credit are
limited to certain percentages of eligible accounts receivable and inventory, as
defined in the credit  agreement.  The credit  facility is  collateralized  by a
security  interest in all of the Company's  assets.  The agreement also contains
restrictions  that require the Company to maintain  certain  financial ratios as
well as restrictions on the payment of cash dividends.  The maturity date of the
line of credit with Commerce Bank is April 1, 2004. The term loan requires equal
monthly  principal  payments  of  $187,000  and  matures on April 1,  2006.  The
mortgage loan requires equal monthly  principal  payments of $19,000 and matures
on April 1, 2017. The mortgage loan is callable after five years at the lender's
option.

     Upon execution of the credit agreement with Commerce Bank,  $14,954,000 was
advanced  to the  Company,  of  which  $14,827,000  was  used to pay all  unpaid
principal and accrued interest under the Company's prior line of credit and term
loans with First Union National Bank.

     At  March  31,  2003,  there  was  $5,595,000,  $6,750,000  and  $3,267,000
outstanding  under the revolving  line of credit,  term loan and mortgage  loan,
respectively.

     At March 31,  2003,  the  Company  was unable to meet one of its  financial
covenants under its credit  agreement with Commerce Bank,  compliance with which
was waived by Commerce Bank as of March 31, 2003.

     The Company paid approximately  $1,880,000 in connection with acquiring its
majority  interest  in BDR  Broadband  and paying  off the Seller  Notes for BDR
Broadband.  In  addition,  the  Company  will incur  additional

                                       10


obligations  in connection  with its  investments  in NetLinc and BTT. While the
Company's  existing  lender  agreed  to allow the  Company  to fund both the BDR
Broadband obligations and the NetLinc/BTT obligations, such lender did not agree
to increase the Company's  line of credit.  This has and may hereafter  decrease
the amount of funds  otherwise  available  to the Company  for  working  capital
purposes.  Accordingly,  if  alternative  financing  is  not  obtained  for  BDR
Broadband  and/or  NetLinc/BTT,  the  Company  may  eventually  need  to seek to
increase  the  amount  of its line of credit  or find an  alternative  financing
source.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     The  market  risk  inherent  in the  Company's  financial  instruments  and
positions represents the potential loss arising from adverse changes in interest
rates.  At  March  31,  2003  and 2002 the  principal  amount  of the  Company's
aggregate  outstanding  variable rate  indebtedness was $5,595,000 and $753,913,
respectively.  A  hypothetical  100 basis point increase in interest rates would
have had an annualized  unfavorable impact of approximately  $56,000 and $8,000,
respectively,  on the  Company's  earnings  and  cash  flows  based  upon  these
quarter-end  debt  levels.  At March  31,  2003,  the  Company  did not have any
derivative financial instruments.

ITEM 4.  CONTROLS AND PROCEDURES

     Within 90 days prior to the date of this report, the Company carried out an
evaluation,  under the supervision and with the  participation  of its principal
executive officer and principal  financial officer,  of the effectiveness of the
design and operation of the Company's disclosure controls and procedures.  Based
on this  evaluation,  the Company's  principal  executive  officer and principal
financial  officer  concluded  that  the  Company's   disclosure   controls  and
procedures  are  effective  in  timely  alerting  them to  material  information
required to be included in the  Company's  periodic  SEC  reports.  It should be
noted that the design of any system of  controls  is based in part upon  certain
assumptions about the likelihood of future events, and there can be no assurance
that any design will succeed in achieving  its stated goals under all  potential
future conditions, regardless of how remote.

     In addition,  the Company  reviewed its internal  controls,  and there have
been no  significant  changes in the  Company's  internal  controls  or in other
factors that could significantly affect those controls subsequent to the date of
their last evaluation.

                                       11


                           PART II - OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

     The Company is a party to certain  proceedings  incidental  to the ordinary
course of its business, none of which, in the current opinion of management,  is
likely to have a material  adverse effect on the Company's  business,  financial
condition, or results of operations.

ITEM 2.  CHANGES IN SECURITIES AND USE OF PROCEEDS

     None.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

     None.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     No matters were  submitted to a vote of security  holders  during the first
quarter ended March 31, 2003 through the solicitation of proxies or otherwise.

ITEM 5.  OTHER INFORMATION

     None.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

     (a)  Exhibits

     The exhibits are listed in the Exhibit Index appearing at page 15 herein.

     (b)  No reports on Form 8-K were filed in the quarter ended March 31, 2003.

                                       12


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

                                        BLONDER TONGUE LABORATORIES, INC.



Date:  May 15, 2003                     By:      /s/  James A. Luksch
                                           -------------------------------------
                                           James A. Luksch
                                           Chief Executive Officer



                                        By:      /s/  Eric Skolnik
                                           -------------------------------------
                                           Eric Skolnik
                                           Senior Vice President and Chief
                                           Financial Officer
                                           (Principal Financial Officer)

                                       13


                                  CERTIFICATION

     I, James A. Luksch, Chief Executive Officer of Blonder Tongue Laboratories,
Inc., certify that:

     1. I have reviewed  this  quarterly  report on Form 10-Q of Blonder  Tongue
Laboratories, Inc.;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

     4. The  registrant's  other  certifying  officers and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

          a) designed  such  disclosure  controls and  procedures to ensure that
     material information relating to the registrant, including its consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  quarterly  report is being
     prepared;

          b) evaluated the effectiveness of the registrant's disclosure controls
     and procedures as of a date within 90 days prior to the filing date of this
     quarterly report (the "Evaluation Date"); and

          c)  presented  in this  quarterly  report  our  conclusions  about the
     effectiveness  of the  disclosure  controls  and  procedures  based  on our
     evaluation as of the Evaluation Date;

     5. The registrant's other certifying  officers and I have disclosed,  based
on our most  recent  evaluation,  to the  registrant's  auditors  and the  audit
committee of the  registrant's  board or directors  (or persons  performing  the
equivalent function):

          a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the  registrant's  ability to record,
     process,  summarize and report  financial data and have  identified for the
     registrant's auditors any material weaknesses in internal controls; and

          b) any fraud,  whether or not material,  that  involves  management or
     other employees who have a significant  role in the  registrant's  internal
     controls; and

     6. The registrant's other certifying  officers and I have indicated in this
quarterly  report  whether or not there  were  significant  changes in  internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of our most recent  evaluation,  including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date:  May 15, 2003

                                                /s/  James A. Luksch
                                                --------------------------------
                                                James A. Luksch
                                                Chief Executive Officer
                                                (Principal Executive Officer)

                                       14


                                  CERTIFICATION

     I, Eric  Skolnik,  Senior Vice  President  and Chief  Financial  Officer of
Blonder Tongue Laboratories, Inc., certify that:

     1. I have reviewed  this  quarterly  report on Form 10-Q of Blonder  Tongue
Laboratories, Inc.;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

     4. The  registrant's  other  certifying  officers and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

          a) designed  such  disclosure  controls and  procedures to ensure that
     material information relating to the registrant, including its consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  quarterly  report is being
     prepared;

          b) evaluated the effectiveness of the registrant's disclosure controls
     and procedures as of a date within 90 days prior to the filing date of this
     quarterly report (the "Evaluation Date"); and

          c)  presented  in this  quarterly  report  our  conclusions  about the
     effectiveness  of the  disclosure  controls  and  procedures  based  on our
     evaluation as of the Evaluation Date;

     5. The registrant's other certifying  officers and I have disclosed,  based
on our most  recent  evaluation,  to the  registrant's  auditors  and the  audit
committee of the  registrant's  board or directors  (or persons  performing  the
equivalent function):

          a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the  registrant's  ability to record,
     process,  summarize and report  financial data and have  identified for the
     registrant's auditors any material weaknesses in internal controls; and

          b) any fraud,  whether or not material,  that  involves  management or
     other employees who have a significant  role in the  registrant's  internal
     controls; and

     6. The registrant's other certifying  officers and I have indicated in this
quarterly  report  whether or not there  were  significant  changes in  internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of our most recent  evaluation,  including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date:  May 15, 2003


                                                /s/  Eric Skolnik
                                                --------------------------------
                                                Eric Skolnik
                                                Senior Vice President and Chief
                                                Financial Officer
                                                (Principal Financial Officer)

                                       15


                                  EXHIBIT INDEX
                                  -------------


Exhibit #               Description                     Location
- ---------               -----------                     --------

3.1            Restated     Certificate    of     Incorporated by reference from
               Incorporation    of    Blonder     Exhibit     3.1     to     S-1
               Tongue Laboratories, Inc.          Registration   Statement   No.
                                                  33-98070    originally   filed
                                                  October 12, 1995, as amended.

3.2            Restated   Bylaws  of  Blonder     Incorporated by reference from
               Tongue Laboratories, Inc.          Exhibit     3.2     to     S-1
                                                  Registration   Statement   No.
                                                  33-98070    originally   filed
                                                  October 12, 1995, as amended.

10.1           Capital Contribution Agreement     Filed herewith
               between     Blonder     Tongue
               Telephone,    LLC,    Resource
               Investment,   LLC,   H.  Tyler
               Bell, NetLinc  Communications,
               LLC   and    Blonder    Tongue
               Laboratories,    Inc.,   dated
               March 26, 2003

99.1           Certification    pursuant   to     Filed herewith.
               Section 906 of  Sarbanes-Oxley
               Act of 2002


                                       16